A timeline from The AIDS Quarterly charting the AIDS epidemic from 1980 through 1988 with a projection of 1992.

A release from the National Institute of Allergy and Infectious Disease discussing their evaluation of how safe AZT treatment for AIDS is on pregnant women.

A press release from Lyphomed announcing the full market approval for NebuPent.

A fact sheet providing up to date information on AIDS resources.

A release from the National Institute of Allergy and Infectious Diseases discussing the promise the drug Zidovudine has shown in clinical trials.

A series of releases from Lyphomed discussing pentamidine isethioniate, a treatment for Pneumocystis Carinii pneuamonia (PCP) that is common in persons with AIDS.

A special report from the Dallas Morning News defining, describing, and providing the history of AIDS.

An agenda from the National Institute of Allergy and Infectious Diseases (NIAID) that charts out the organization's hopes for HIV/AIDS treatment and prevention.

A series of documents addressing the planning of the Sixth International Conference on AIDS and the implications of a new immigration policy that would impact persons with HIV/AIDS.

A release from the National Institute of Allergy and Infectious Diseases discussing the new prototype AIDS vaccine that shows great promise.

A release from the AIDS Clinical Trials Alert discussing Phase I of clinical trials for Peptide T.

A scholarly article about how mineral oil lube, common in hand lotion, causes latex condoms to deteriorate.

A series of documents concerning NIAID, an experimental AIDS vaccine, that is in its second phase of clinical trials and about how the researchers are looking for volunteers to participate in the study.

An agenda from the National Institute of Allergy and Infectious Disease discussing their goals including to investigate the safety of AZT for HIV positive pregnant women.

A newspaper clipping from the New York Times discussing two recent studies proving that lower doses of AZT are just as effective in treating HIV/AIDS and with fewer side effects but that the government is lagging in approving a lowering of standard dosage.

A release from the National Institute of Allergy and Infectious Disease addressing a study that confirmed AZT and interferon-alpha used together can treat Kaposi's sarcoma, a common AIDS related complication.

An agenda for the National Institute of Allergy and Infectious Disease for November 1989 that discusses funding and research.

Informational sheet from the AIDS Quarterly with talking points on the AIDS pandemic from the Center for Disease Control.

A Dallas County Report about communicable diseases rates of infection and death.

Updates from the National Institute of Allergy and Infectious Diseases presenting HIV/AIDS updates before their fifth International AIDS Conference.

Letter from U.S. Immigration Service to the co-chairs of the Sixth International Conference on AIDS explaining the particular case of one gay man refused admission into the United States.

Letter from Richard E. Norton at the U.S. Department of Justice to the co-chairs of the Sixth International Conference on AIDS, Paul Volberding and John Ziegler, in response to their previous correspondence. The letter addresses the inability of Henry Wilson and Knud Josephsen to enter the United States for the conference and explains that their medical status (as HIV-infected individuals) was not a factor in denying them admission.

A newspaper clipping from the New York Times discussing research for AIDS treatment derived from a Chinese plant.

A newspaper clipping from the New York Times addressing the massive amount of AIDS cases that go unreported nationwide and the problem that poses to researchers and public health.